149 related articles for article (PubMed ID: 37482545)
1. PRKAA1 predicts prognosis and is associated with immune characteristics in gastric cancer.
Chen Y; Chen S; Zhu J; Yang S; Yu Q; Xu S
Funct Integr Genomics; 2023 Jul; 23(3):252. PubMed ID: 37482545
[TBL] [Abstract][Full Text] [Related]
2. Involvement of NF-κB signaling pathway in the regulation of PRKAA1-mediated tumorigenesis in gastric cancer.
Zhang Y; Zhou X; Zhang Q; Zhang Y; Wang X; Cheng L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3677-3686. PubMed ID: 31841039
[TBL] [Abstract][Full Text] [Related]
3. TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer.
Dargiene G; Streleckiene G; Skieceviciene J; Leja M; Link A; Wex T; Kupcinskas L; Malfertheiner P; Kupcinskas J
J Gastrointestin Liver Dis; 2018 Dec; 27(4):363-369. PubMed ID: 30574617
[TBL] [Abstract][Full Text] [Related]
4. PRKAA1 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer Cells Through Activating JNK1 and Akt Pathways.
Zhang Y; Zhou X; Cheng L; Wang X; Zhang Q; Zhang Y; Sun S
Oncol Res; 2020 May; 28(3):213-223. PubMed ID: 31558185
[TBL] [Abstract][Full Text] [Related]
5. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
6. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
7. Association of PTGER4 and PRKAA1 genetic polymorphisms with gastric cancer.
Yu S; Tu R; Chen Z; Song J; Li P; Hu F; Yuan G; Zhang R; Li Y
BMC Med Genomics; 2023 Sep; 16(1):209. PubMed ID: 37670284
[TBL] [Abstract][Full Text] [Related]
8. Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review.
Meng J; Fan X; Zhang M; Hao Z; Liang C
BMC Med Genet; 2018 Oct; 19(1):189. PubMed ID: 30340465
[TBL] [Abstract][Full Text] [Related]
9. Association between PRKAA1 rs13361707 T>C polymorphism and gastric cancer risk: Evidence based on a meta-analysis.
Jiang Y; Li W; Lu J; Zhao X; Li L
Medicine (Baltimore); 2018 Apr; 97(14):e0302. PubMed ID: 29620653
[TBL] [Abstract][Full Text] [Related]
10. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y
Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
Chen M; Jiang B; He B; Tang M; Wang P; Chen L; Lu J; Lu P
BMC Cancer; 2018 Sep; 18(1):923. PubMed ID: 30253744
[TBL] [Abstract][Full Text] [Related]
12. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
Zhu H; Wang G; Zhu H; Xu A
J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
[No Abstract] [Full Text] [Related]
13. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
14. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Liu B; Xiao X; Lin Z; Lou Y; Zhao L
Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
[TBL] [Abstract][Full Text] [Related]
15. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Wang M; Li C; Liu Y; Wang Z
Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
[TBL] [Abstract][Full Text] [Related]
16. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
17. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
19. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
Ren S; Chen M; Chen Y; Ding K
Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
[TBL] [Abstract][Full Text] [Related]
20.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
